Eaton-Lambert Syndrome

Revisión del 10:04 20 ene 2016 de Kshigyo (discusión | contribs.) (Eaton-Lambert Syndrome)
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

Background

  • Disease of the neuromuscular junction leading to primary presentation of weakness
  • Caused by auto-antibodies against the voltage-gated calcium channels at the NMJ

Clinical Features

  • Often presents with alteration in gait or difficulty rising from a chair
  • Symmetrical muscle weakness and fatiguability often beginning in lower extremities
  • Autonomic dysfunction (dry mouth, erectile dysfunction)
  • Compared with myastenia gravis, ELS begins with lower extremities weakness and rarely begins with extraocular muscle weakness
  • Respiratory failure can occur in late stages of the disease
  • Paraneoplastic and autoimmune form of LEMS have similar signs and symptoms

Differential Diagnosis

  • Myasthenia Gravis
  • Myositis
  • Dermatomyositis
  • Amyotrophic Lateral Sclerosis
  • Limb-Girdle Muscle Dystrophy
  • Inclusion Body Myositis

Diagnosis

  • Diagnosis is generally a clinical diagnosis
  • Confirmation testing for VGCC antibodies
  • Neurophysiologic testing

Management

  • Guanidine
  • Aminopyridines
  • Acetylcholinesterase inhibitors
  • IVIG
  • Glucocorticoids
  • Plasma exchange

Disposition

  • Referral to rheumatology
  • Any patients with risk factors for small cell lung cancer will need to be referred for evaluation of underlying malignancy

See Also

External Links

References

<UpToDate>